Nephros, Inc. (NEPH) Stock Analysis & Investment Frameworks
Nephros, Inc. (NEPH) stock analysis on Invetso. Review Nephros, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Nephros, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
Nephros, Inc. Key Financial Metrics
- Market Cap: $33.59M
- Revenue: $18.79M
- P/E Ratio: 28.09
- ROE: 16.83%
- ROIC: 13.64%
- Dividend Yield: N/A
About Nephros, Inc.
Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.
Nephros, Inc. Investment Frameworks
Invetso analyzes Nephros, Inc. (NEPH) across the following frameworks:
- Nephros, Inc. 10Y Growth Potential
- Nephros, Inc. Scenario Analysis
- Nephros, Inc. Risks & Opportunities
- Nephros, Inc. Economic Moat
- Nephros, Inc. Business Model
- Nephros, Inc. Management
- Nephros, Inc. SWOT Analysis
- Nephros, Inc. Porter's 5 Forces
- Nephros, Inc. PESTLE Analysis
- Nephros, Inc. ESG Analysis